Removal and insertion of central venous catheters in cancer patients is associated with high symptom burden

Sammy Raad(The University of Texas MD Anderson Cancer Center), Joel Rosenblatt(The University of Texas MD Anderson Cancer Center), Ray Hachem(The University of Texas MD Anderson Cancer Center), Pankil Shah(Mays Cancer Center at UT Health San Antonio), Anne Marie Chaftari(The University of Texas MD Anderson Cancer Center), Charles S. Cleeland(The University of Texas MD Anderson Cancer Center), Elizabeth Natividad(The University of Texas MD Anderson Cancer Center)
Expert Review of Medical Devices
August 1, 2018
10.1080/17434440.2018.1500892
Cited by 8

Related Papers

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations
|Pain|2003|3.5k
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters
|New England Journal of Medicine|1999|806